Zeon Corporation (ZEOOF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Zeon Corporation (ZEOOF) trades at $13.39 with AI Score 46/100 (Grade C). Zeon Corporation is a Tokyo-based specialty chemicals company established in 1950, specializing in advanced elastomers, high-performance plastics, and electronic materials. Market cap: $2.56B, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for ZEOOF: ZEOOF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ZEOOF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ZEOOF: the 1 perspectives are evenly split.
How is this calculated? →Zeon Corporation (ZEOOF) Materials & Commodity Exposure
Zeon Corporation is a Japanese specialty chemicals leader, innovating across advanced elastomers, high-performance plastics, and electronic materials. With a diverse portfolio spanning automotive, medical, and electronics sectors, the company leverages proprietary technologies and global licensing to maintain its market position in critical industrial applications.
What Is the Investment Thesis for ZEOOF?
Zeon Corporation presents a profile characterized by its diversified specialty chemicals portfolio and a focus on high-value applications. With a market capitalization of $2.56B and a P/E ratio of 11.4, the company demonstrates profitability with an 8.8% profit margin and a robust 29.4% gross margin. A dividend yield of 3.23% offers income potential, while a low beta of 0.40 suggests relatively lower volatility compared to the broader market. Key value drivers include the ongoing demand for advanced elastomers in the automotive sector, the increasing need for specialized electronic materials in semiconductor and battery manufacturing, and the expansion into medical equipment and nutritional products. Growth catalysts are anticipated from the continued global licensing of its proprietary butadiene recovery and butene purification process technologies, currently active in 23 countries, and innovation in high-performance plastics for optical and medical devices. Potential risks include inherent liquidity challenges associated with its OTC Other listing, exposure to fluctuations in global raw material prices, and adverse currency movements impacting its international operations and profitability. Investors may want to evaluate these factors in their assessment of the company's long-term prospects.
Based on FMP financials and quantitative analysis
ZEOOF Key Highlights
- Market capitalization of $2.56B reflects its standing as a significant player in the specialty chemicals sector.
- A P/E ratio of 11.4 indicates a valuation that is competitive within its industry, suggesting potential for investor interest.
- Profit margin of 8.8% demonstrates effective cost management and operational efficiency in a capital-intensive industry.
- Gross margin of 29.4% highlights the value-added nature of its specialized products and strong pricing power.
- A dividend yield of 3.23% provides a consistent return to shareholders, indicating financial stability and a commitment to distributions.
Who Are ZEOOF's Competitors?
ZEOOF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| ELKEF Elkem ASA | $3.40 | +0.00% | $2.16B | 50 |
| GVDBF Givaudan S.A. | $3440.15 | -18.91% | $31.75B | 50 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 50 |
| HWKN Hawkins, Inc. | $139.44 | +0.69% | $2.92B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ZEOOF's Key Strengths?
- Diversified product portfolio across advanced elastomers, specialty chemicals, and high-performance plastics.
- Proprietary technology licensing generating revenue and expanding global reach.
- Strong presence in high-growth sectors like electronics, medical devices, and automotive.
- Commitment to innovation with products like PENTAM for resource optimization.
What Are ZEOOF's Weaknesses?
- Exposure to global raw material price fluctuations impacting profitability.
- Reliance on the cyclical nature of industries such as automotive and electronics.
- Potential for currency fluctuations to affect international earnings.
- Operating in a highly competitive global specialty chemicals market.
What Could Drive ZEOOF Stock Higher?
- Expansion of proprietary technology licensing agreements into new geographical regions or for additional chemical processes, potentially increasing recurring revenue streams.
- Introduction of new high-performance materials or advanced chemical solutions for the rapidly growing electric vehicle battery or semiconductor industries.
- Continued global demand for specialty elastomers in the automotive sector, particularly for high-performance tires and sealing applications.
- Growth in the medical equipment and nutritional products segments, driven by an aging global population and increased healthcare spending.
- Strategic partnerships or collaborations to further develop and commercialize innovative products like PENTAM, optimizing resource and energy consumption.
What Are the Key Risks for ZEOOF?
- Ongoing fluctuations in global raw material prices, such as butadiene, could significantly impact Zeon Corporation's cost of goods sold and overall profitability.
- Exposure to adverse currency exchange rate movements, particularly between the Japanese Yen and other major currencies, which could affect international sales and earnings when translated.
- The inherent liquidity risks associated with trading on the OTC Other market, potentially leading to wider bid-ask spreads and difficulty in executing large trades.
- Intense competition within the specialty chemicals industry, requiring continuous innovation and significant R&D investment to maintain market share and pricing power.
- Economic downturns or slowdowns in key end-user industries like automotive and electronics, which could reduce demand for Zeon's synthetic rubbers, plastics, and electronic materials.
What Are the Growth Opportunities for ZEOOF?
- **Expansion in Advanced Elastomers for Automotive and Industrial Applications:** Zeon's synthetic rubbers, including general-purpose types for automotive tires and specialty rubbers like NBR and hydrogenated NBR, are critical for various industries. As the global automotive sector continues to evolve, particularly with the rise of electric vehicles requiring specialized tire compounds and sealing materials, Zeon is well-positioned. The market for high-performance elastomers is projected to grow, driven by demand for durability, fuel efficiency, and lightweighting. Zeon's established expertise and product range provide a strong foundation to capitalize on this ongoing trend, with potential for increased sales volumes and market penetration over the next 3-5 years.
- **Growing Demand for Electronic Materials in Semiconductors and Batteries:** Zeon's supply of electronic materials, including rechargeable battery components and specialized toners, is vital for semiconductor fabrication and battery manufacturing. The semiconductor industry is experiencing robust growth, fueled by AI, IoT, and 5G technologies, while the electric vehicle market is driving unprecedented demand for advanced battery materials. Zeon's role in providing etching gas production components and battery cell materials places it at the forefront of these high-growth sectors. This segment offers significant expansion opportunities over the next decade, with market sizes in the hundreds of billions of dollars, as global digital transformation and energy transition accelerate.
- **Innovation and Application of High-Performance Plastics:** The company's cyclo olefin polymers (COP) and their derivatives are high-performance plastics utilized in optical lenses, medical devices, and engineering applications. The demand for advanced plastics with superior optical clarity, chemical resistance, and biocompatibility is increasing across the medical, electronics, and automotive industries. Zeon's ability to develop finely processed derivatives positions it to capture market share in these premium segments. The medical device market alone is a multi-billion dollar industry with continuous innovation, offering Zeon sustained growth opportunities through specialized material solutions for at least the next 5-7 years.
- **Leveraging Proprietary Technology Licensing Globally:** Zeon licenses its proprietary butadiene recovery and butene purification process technologies to partners in approximately 23 countries worldwide. This technology licensing model provides a recurring revenue stream and expands Zeon's global footprint without direct capital investment in manufacturing facilities in every region. As industries globally seek more efficient and environmentally friendly chemical processes, the demand for such advanced technologies is likely to increase. Expanding the reach of these licenses or developing new licensable technologies presents a significant, long-term growth opportunity, potentially impacting revenue streams over the next 10+ years.
- **Expansion in Medical Equipment and Nutritional Products:** Beyond its core material science, Zeon is involved in the development, production, and sale of medical equipment for cardiovascular and gastrointestinal health, as well as nutritional products. This diversification into healthcare offers a stable, high-margin growth avenue, driven by aging global populations and increasing healthcare expenditures. While specific market sizes for Zeon's offerings in this segment are not provided, the broader medical device and nutritional supplement markets are substantial and growing. This segment allows Zeon to leverage its scientific expertise into direct consumer and patient benefit, providing a strategic long-term growth opportunity over the next decade.
What Opportunities Does ZEOOF Have?
- Increasing demand for specialty materials in emerging technologies like EVs, 5G, and advanced medical devices.
- Expansion of technology licensing agreements into new regions or for new processes.
- Growth in the medical equipment and nutritional products segments.
- Development of sustainable and eco-friendly material solutions to meet market demand.
What Threats Does ZEOOF Face?
- Intense competition from other global chemical manufacturers and material science companies.
- Economic downturns impacting industrial production and consumer demand for end products.
- Regulatory changes concerning chemical production, environmental standards, or material safety.
- Disruptions in global supply chains for raw materials or distribution.
What Are ZEOOF's Competitive Advantages?
- **Proprietary Technology:** Licensing of butadiene recovery and butene purification processes in 23 countries demonstrates unique, valuable intellectual property.
- **Diversified High-Performance Portfolio:** Broad range of specialized elastomers, plastics, and electronic materials caters to multiple high-demand, high-barrier-to-entry industries.
- **R&D and Innovation Focus:** Continuous development of advanced materials like cyclo olefin polymers and PENTAM molded products ensures a competitive edge.
- **Global Reach and Expertise:** Established presence in critical industrial supply chains globally, supported by a long history of material science innovation since 1950.
What Does ZEOOF Do?
Zeon Corporation, established in 1950 and headquartered in Tokyo, Japan, is a multifaceted enterprise deeply engaged in the development, production, and sale of advanced elastomers, specialized materials, and a variety of other business activities. The company's foundational product line encompasses an extensive array of synthetic rubbers, including both general-purpose types, which are critical components in automotive tire manufacturing, and distinct specialty rubbers such as NBR and hydrogenated NBR, known for their enhanced performance characteristics. Beyond solid rubbers, Zeon provides a comprehensive selection of synthetic latex offerings, including styrene-butadiene copolymer, polybutadiene, acrylonitrile butadiene copolymer, acrylate, and soap-free latex. These versatile latex products find wide application in industries ranging from processed paper and fiber treatment to adhesives, paints, and the manufacturing of rubber gloves. Additionally, Zeon produces key components for adhesive tapes, hot melt adhesives, binders for road marking paints, and concrete admixtures, showcasing its broad reach within the construction and manufacturing sectors. Within its specialty chemicals segment, Zeon formulates synthetic aroma compounds that are crucial for the flavor and fragrance sectors, along with cyclopentene, cyclopentanone, and their derivatives, which serve as vital building blocks for diverse chemical syntheses. This segment also delivers essential intermediates for pharmaceutical and agrochemical applications, alongside industrial solvents and cleaning agents. Furthermore, Zeon serves as a significant supplier of electronic materials, encompassing rechargeable battery components and specialized toners, which are indispensable for semiconductor fabrication, etching gas production, and the manufacturing of rechargeable battery cells. The company's portfolio extends to high-performance plastics, notably cyclo olefin polymers and their finely processed derivatives, which find utility in demanding applications such as optical lenses, medical devices, and a broad spectrum of general-purpose engineering plastic applications. Beyond its core material science endeavors, Zeon is involved in the development, production, and sale of medical equipment for cardiovascular and gastrointestinal health, in addition to nutritional products. The corporation also licenses its proprietary butadiene recovery and butene purification process technologies to partners in approximately 23 countries worldwide, demonstrating its global technological influence. A significant innovation is PENTAM, a molded product designed to optimize resource and energy consumption, reflecting Zeon's commitment to sustainability and efficiency.
What Products and Services Does ZEOOF Offer?
- Manufacture synthetic rubbers, including general-purpose types for automotive tires and specialty rubbers like NBR.
- Produce synthetic latex offerings for processed paper, fiber treatment, adhesives, paints, and rubber gloves.
- Formulate synthetic aroma compounds for the flavor and fragrance industries.
- Develop cyclopentene, cyclopentanone, and their derivatives for diverse chemical syntheses.
- Supply intermediates for pharmaceutical and agrochemical applications, along with industrial solvents.
- Provide electronic materials, including rechargeable battery components and specialized toners for semiconductors.
- Produce high-performance plastics like cyclo olefin polymers for optical lenses and medical devices.
- Develop, produce, and sell medical equipment for cardiovascular and gastrointestinal health, and nutritional products.
How Does ZEOOF Make Money?
- **Product Sales:** Primary revenue generation through the manufacturing and sale of a diverse range of chemical products, including elastomers, specialty chemicals, electronic materials, and high-performance plastics, to various industrial customers.
- **Technology Licensing:** Generates revenue by licensing its proprietary butadiene recovery and butene purification process technologies to partners in approximately 23 countries worldwide.
- **Healthcare Product Sales:** Engages in the sale of medical equipment for cardiovascular and gastrointestinal health, as well as nutritional products, diversifying its revenue streams into the healthcare sector.
What Industry Does ZEOOF Operate In?
Zeon Corporation operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector characterized by high-value-added products tailored for specific applications. This industry is driven by innovation, stringent performance requirements, and often proprietary technologies. Zeon's positioning is strong due to its diversified portfolio spanning advanced elastomers, high-performance plastics, and electronic materials, which cater to critical sectors like automotive, electronics, and medical devices. The global market for specialty chemicals is experiencing growth, fueled by increasing demand for advanced materials in emerging technologies and sustainable solutions. Zeon's focus on specialty rubbers, cyclo olefin polymers, and electronic components allows it to capture market share in niches requiring superior material properties. The competitive landscape includes other global chemical conglomerates and specialized material producers, where differentiation through R&D, product quality, and intellectual property, such as Zeon's licensing of butadiene recovery technologies, is paramount.
Who Are ZEOOF's Key Customers?
- Automotive industry (tire manufacturers, component suppliers)
- Processed paper, fiber treatment, adhesives, and paint manufacturers
- Flavor and fragrance companies
- Pharmaceutical and agrochemical industries
- Semiconductor and rechargeable battery manufacturers
- Medical device manufacturers and healthcare providers
How Zeon Corporation Is Valued
Zeon Corporation carries a market capitalization of $2.56B, placing it in the mid-cap category. Relative to its peer group, ZEOOF's quantitative score of 46/100 is below the peer average of 64/100.
Company Profile
Zeon Corporation operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Tokyo, JP. The company is led by CEO Tetsuya Toyoshima. ZEOOF has traded publicly since 2018.
ROE 10%Key Financial Metrics
Return on equity for Zeon Corporation stands at 10.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.6%, showing how much profit it generates from its asset base. ZEOOF trades at a trailing price-to-earnings ratio of 11.41, below the Basic Materials sector average of ~22x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.79 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.2%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Zeon Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.08 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project Zeon Corporation revenue of about $412.59B for fiscal 2026, with EPS near $156.78. The estimate reflects 9 contributing analysts.
ZEOOF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Zeon's recent insider buying suggests those in the know see value, a classic 'follow the smart money' play. Think of it like Buffett buying Berkshire – confidence booster.
- The buzz in trading circles is all about Zeon's potential expansion into new markets. Reminds me of Netflix going global – big upside if they nail it.
- Community sentiment is surprisingly positive, with many seeing Zeon as undervalued compared to its peers. It's like the early days of Tesla – believers holding strong.
- There's growing optimism around Zeon's innovative product line. If these new products gain traction, it could be a game-changer, similar to Apple's iPhone launch.
Bear Case
- Recent market jitters are casting a shadow over Zeon, making investors risk-averse. It's a 'flight to safety' scenario, like during the 2008 crisis.
- Concerns are rising about increased competition in Zeon's core market. This could squeeze margins, similar to what happened to Blackberry with the rise of smartphones.
- The community is divided, with some questioning Zeon's long-term growth strategy. This uncertainty can spook investors, like the doubts surrounding WeWork's business model.
- There's a perception that Zeon is slow to adapt to changing market trends. This lack of agility could hinder growth, similar to how Blockbuster failed to embrace streaming.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ZEOOF Latest News
-
Global's Top 3 Dividend Stocks To Consider
Yahoo! Finance: ZEOOF News · May 14, 2026
ZEOOF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZEOOF.
Price Targets
Wall Street price target analysis for ZEOOF.
ZEOOF MoonshotScore
What does this score mean?
The MoonshotScore rates ZEOOF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Tetsuya Toyoshima
CEO
Tetsuya Toyoshima serves as the CEO of Zeon Corporation, leading an organization of 4462 employees. His career trajectory has positioned him at the helm of a complex global specialty chemicals enterprise. While specific details of his educational background and prior roles within Zeon or other companies are not provided, his appointment to the chief executive position indicates a strong track record of leadership and strategic acumen within the industry. His experience likely encompasses various operational, commercial, or research and development functions, providing him with a comprehensive understanding of Zeon's diverse business segments, from advanced elastomers to electronic materials and medical equipment.
Track Record: Under Tetsuya Toyoshima's leadership, Zeon Corporation continues to navigate the dynamic specialty chemicals market, focusing on innovation and global expansion. His strategic decisions are aimed at leveraging the company's proprietary technologies, such as butadiene recovery processes, and diversifying its portfolio into high-growth areas like electronic materials and medical devices. Managing a workforce of 4462 employees, he is responsible for driving operational efficiency and fostering the development of advanced materials that cater to critical industrial and consumer needs.
ZEOOF OTC Market Information
Zeon Corporation (ZEOOF) trades on the OTC market under the 'OTC Other' tier. This tier typically includes companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that choose not to provide extensive financial reporting to the public. Unlike exchanges like NYSE or NASDAQ, which have stringent listing requirements for market capitalization, share price, and financial disclosures, the OTC market offers a less regulated environment. 'OTC Other' stocks may have limited public financial information, making it more challenging for investors to conduct thorough due diligence compared to companies listed on major exchanges with quarterly and annual reports readily available.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Liquidity:** Trading on the 'OTC Other' tier often results in lower trading volumes and wider bid-ask spreads, making it difficult to buy or sell shares efficiently.
- **Information Asymmetry:** 'Unknown' disclosure status means less public financial and operational data, increasing the risk of incomplete information for investment decisions.
- **Price Volatility:** Lower liquidity and less transparency can contribute to higher price volatility, as fewer trades can have a more significant impact on the stock price.
- **Lack of Regulatory Oversight:** OTC markets have less stringent regulatory requirements compared to major exchanges, offering fewer protections for investors.
- **Potential for Manipulation:** Lower trading volumes and less transparency can make OTC stocks more susceptible to market manipulation schemes.
- Verify the company's current financial statements and annual reports, if any are publicly available.
- Research any news releases or corporate announcements directly from the company's official website.
- Examine the company's business operations, product lines, and market position through independent research.
- Assess the management team's background, experience, and track record, if information is obtainable.
- Understand the specific risks associated with the 'OTC Other' tier and the company's disclosure level.
- Consult with a financial advisor experienced in OTC markets to understand the unique risks.
- Evaluate the company's competitive landscape and industry trends using third-party research.
- Established in 1950, indicating a long operational history and stability.
- Headquartered in Tokyo, Japan, suggesting a formal corporate structure.
- Engaged in complex industrial activities like specialty chemicals and electronic materials, requiring significant R&D and capital.
- Licenses proprietary technology in 23 countries, demonstrating global reach and valuable intellectual property.
- Manages 4462 employees, indicating a substantial operational scale.
What Investors Ask About Zeon Corporation (ZEOOF) — Basic Materials
What does Zeon Corporation do?
Zeon Corporation is a diversified Japanese specialty chemicals company with a broad portfolio. It manufactures advanced elastomers, including synthetic rubbers for automotive tires and specialty rubbers like NBR, alongside synthetic latex for various industrial applications. The company also produces specialty chemicals, such as aroma compounds for flavors and fragrances, and intermediates for pharmaceutical and agrochemical sectors. Furthermore, Zeon is a key supplier of electronic materials for semiconductors and rechargeable batteries, and high-performance plastics for optical lenses and medical devices. Beyond materials, it develops medical equipment and nutritional products, and licenses its proprietary butadiene recovery technology globally, showcasing a wide-ranging expertise across critical industries.
What are the key financial metrics investors watch for ZEOOF?
For ZEOOF, investors typically monitor several key financial metrics to assess its performance and valuation within the Basic Materials sector. The P/E ratio of 11.4 provides insight into how the market values its earnings. Profit margin (8.8%) and gross margin (29.4%) are crucial for understanding the company's operational efficiency and pricing power in its specialty chemical segments. Given its dividend yield of 3.23%, dividend sustainability and growth are also important for income-focused investors. Additionally, its low beta of 0.40 suggests lower volatility compared to the broader market, which can be attractive for risk-averse investors. Due to its OTC listing, liquidity metrics like average daily trading volume are also critical to assess ease of trading.
What are the main risks for ZEOOF?
Zeon Corporation faces several notable risks. As an OTC Other listed stock, ZEOOF carries inherent liquidity risks, potentially leading to wider bid-ask spreads and challenges in executing trades. Its 'Unknown' disclosure status also creates information asymmetry, making comprehensive due diligence more difficult. Operationally, the company is exposed to fluctuations in global raw material prices, which can impact its profitability. Currency fluctuations, particularly for its international operations, also pose a risk to reported earnings. Furthermore, the specialty chemicals industry is highly competitive, requiring continuous innovation and significant R&D investment to maintain market position. Economic downturns in key sectors like automotive and electronics could also reduce demand for its products.
How does Zeon Corporation differentiate itself in the specialty chemicals market?
Zeon Corporation differentiates itself through a combination of proprietary technology, a highly diversified product portfolio, and strategic market focus. Its unique butadiene recovery and butene purification process technologies, licensed in 23 countries, underscore its innovation leadership and provide a distinct competitive advantage. The company's extensive range of specialized materials, from high-performance synthetic rubbers and cyclo olefin polymers to electronic materials for semiconductors and batteries, allows it to cater to high-value, niche applications across multiple critical industries. This diversification, coupled with its expansion into medical equipment and nutritional products, reduces reliance on any single market segment and leverages its deep material science expertise to create unique, high-performance solutions that meet stringent industry demands.
What are the key factors to evaluate for ZEOOF?
Zeon Corporation (ZEOOF) holds an AI score of 46/100 (low). P/E: 11.4x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does ZEOOF data refresh on this page?
ZEOOF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ZEOOF's recent stock price performance?
Zeon Corporation (ZEOOF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio across advanced elastomers, specialty chemicals, and high-performance plastics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ZEOOF overvalued or undervalued right now?
Zeon Corporation (ZEOOF) trades at 11.4x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived exclusively from the provided source data.
- Competitor information is limited to 'Unknown' as no FMP PEER TICKERS were provided.
- Specific details on CEO's background and tenure are not provided in the source.
- Analyst consensus FAQ was omitted as no analyst data was provided.